Mr. Lonner has been Group President and Chief Executive Officer and a board member of Meda AB, a leading international specialty pharmaceutical company, since 1999. Prior to joining Meda AB, Mr. Lonner was Vice President, Nordic Region for Astra and then CEO of KaroBio. He also was the former Head of the Association for Pharmaceutical Companies in
About Valeant
Valeant Pharmaceuticals International (NYSE: VRX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of neurology and dermatology. More information about Valeant can be found at www.valeant.com.
(Logo: http://www.newscom.com/cgi-bin/prnh/20081125/VALEANTLOGO)
Contact: Laurie W. Little Valeant Pharmaceuticals 949-461-6002
SOURCE Valeant Pharmaceuticals International